- Home
- RMCF vs CODX Comparison
RMCF vs CODX Comparison
Compare RMCF & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMCF
- CODX
- Stock Information
- Founded
- RMCF 1981
- CODX 2013
- Country
- RMCF United States
- CODX United States
- Employees
- RMCF N/A
- CODX N/A
- Industry
- RMCF Specialty Foods
- CODX Medical/Dental Instruments
- Sector
- RMCF Consumer Staples
- CODX Health Care
- Exchange
- RMCF Nasdaq
- CODX Nasdaq
- Market Cap
- RMCF 11.4M
- CODX 9.8M
- IPO Year
- RMCF N/A
- CODX 2017
- Fundamental
- Price
- RMCF $1.53
- CODX $0.34
- Analyst Decision
- RMCF
- CODX Buy
- Analyst Count
- RMCF 0
- CODX 2
- Target Price
- RMCF N/A
- CODX $5.50
- AVG Volume (30 Days)
- RMCF 22.7K
- CODX 5.1M
- Earning Date
- RMCF 10-14-2025
- CODX 11-06-2025
- Dividend Yield
- RMCF N/A
- CODX N/A
- EPS Growth
- RMCF N/A
- CODX N/A
- EPS
- RMCF N/A
- CODX N/A
- Revenue
- RMCF $29,545,000.00
- CODX $1,003,653.00
- Revenue This Year
- RMCF N/A
- CODX N/A
- Revenue Next Year
- RMCF N/A
- CODX $31.58
- P/E Ratio
- RMCF N/A
- CODX N/A
- Revenue Growth
- RMCF 5.81
- CODX N/A
- 52 Week Low
- RMCF $1.12
- CODX $0.23
- 52 Week High
- RMCF $3.49
- CODX $1.40
- Technical
- Relative Strength Index (RSI)
- RMCF 52.55
- CODX 62.83
- Support Level
- RMCF $1.41
- CODX $0.30
- Resistance Level
- RMCF $1.50
- CODX $0.33
- Average True Range (ATR)
- RMCF 0.07
- CODX 0.03
- MACD
- RMCF 0.01
- CODX 0.00
- Stochastic Oscillator
- RMCF 74.85
- CODX 60.32
About RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.